Poznámky k epizodě
Psychedelic medicines can open a door. But what happens when there's nothing waiting on the other side to help you stay open?
In this episode, Dr. Rosalind Watts tells the story of John, a participant in one of the first psilocybin trials for depression. Through John's story, Ros explores a question that sits at the heart of modern psychedelic care: what happens after the breakthrough?
Along the way, she reflects on a major new U.S. executive order designed to accelerate access to psychedelic medicines, and the mix of hope and ethical tensions it raises.
Ultimately, this episode asks a…

